Detalles de la búsqueda
1.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608183
2.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26458240
3.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107338
4.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
Biol Blood Marrow Transplant
; 21(11): 1932-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099830
5.
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
Br J Haematol
; 166(1): 118-29, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673727
6.
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation.
Infect Agent Cancer
; 17(1): 41, 2022 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922822
7.
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
Cancers (Basel)
; 14(23)2022 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497328
8.
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
Br J Haematol
; 154(5): 579-89, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21707585
9.
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Eur J Haematol
; 87(6): 547-53, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21752099
10.
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab.
Infect Agent Cancer
; 16(1): 38, 2021 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34078415
11.
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.
Am J Hematol
; 85(1): 87-90, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20029955
12.
Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report.
Onco Targets Ther
; 8: 401-4, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25709472
13.
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
Cancer Chemother Pharmacol
; 64(5): 907-16, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19219604
14.
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
Am J Hematol
; 81(8): 598-602, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16823816
Resultados
1 -
14
de 14
1
Próxima >
>>